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creativecommons.org/licenses/by-nc-nd/Abstract Objective: The European Organisation for Research and Treatment of Cancer
(EORTC) core questionnaire, QLQ-C30, is a frequently used patient-reported
outcome (PRO) instrument to assess health-related quality of life of patients with cancer.
To enhance the understanding and interpretation of PRO data, it is important to obtain norm
data from the general population. This article presents updated general population norm data
for the EORTC QLQ-C30 for Germany.
Methods: Data were obtained as part of a larger study collecting EORTC QLQ-C30 norm
data across 15 countries via an online survey. After linear transformation of EORTC QLQ-
C30 raw scores, data were weighted based on the United Nations’ population distribution sta-
tistics. Data are presented by age and sex/age.
Results: A total of 1006 Germans responded to the survey. Across EORTC QLQ-C30 do-
mains, different response patterns were observed, with men generally scoring better, that is,
higher in most function scales and lower in most symptom scales/items than women. For
age, mixed patterns were observed. While older respondents scored worse/lower in physical
and role functioning, emotional functioning scores appeared to increase with increasing age.
For the symptom scales/items, some symptoms were relatively stable across age groups, whileiversita¨tsmedizin Berlin, Corporate Member of Freie Universita¨t Berlin, Humboldt-Universita¨t zu Berlin,
artment, Division of Psychosomatic Medicine, Charite´platz 1, 10117, Berlin, Germany.
e.de (S. Nolte).
blished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
4.0/).
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Conclusions: This study presents updated EORTC QLQ-C30 general population norm data
for Germany that can readily be used for comparative purposes with data obtained from pa-
tients with cancer.
ª 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Many short- and long-term constraints and side-effects
resulting from cancer and its treatment are related to the
subjective experience of the individual. Therefore, the
assessment of patient-reported outcome (PRO) data is
becoming increasingly important not only in oncological
practice and research but also in the development and
regulatory evaluation of cancer drugs [1e3]. However,
the measurement and interpretation of patients’ self-
reported health-related quality of life (HRQoL) scores,
a subtype of PRO data, come with methodological
challenges, such as score interpretation. For example, to
interpret scores and to understand how specific scores
compare with other groups, a sensible comparator
should be selected (e.g. other patients with cancer, norm
data obtained from the general population and so on).
The European Organisation for Research and Treat-
ment of Cancer (EORTC) core questionnaire, QLQ-C30,
is a frequently used PRO instrument to assess HRQoL of
patients with cancer. It covers 15 domains/aspects of
HRQoL, including a global health/quality of life (QoL)
score [4]. For the understanding and interpretation of
EORTC QLQ-C30 data by use of a comparator, several
efforts have already been undertaken. For example, for
the comparison of EORTC QLQ-C30 data with data
from other patients with cancer, reference values from
various oncological populations exist [5]. Further, general
population norm data are available for several European
countries [6e14], including four studies on the German
general population [15e18].
Despite the great efforts to generate general population
norm data, the publication of various normative samples
since the late 1990s has led to several challenges. At the
national level, for example, different sampling strategies
were applied across the four German studies, leading to
differences between the studies [15e18]. In the context of
multinational studies, uniform general population norm
data are even more difficult to establish, unless HRQoL
scores are obtained as part of a concerted data collection
effort. A first attempt to provide summaryEuropean norm
data was undertaken in 2014 by collating data from pre-
viously published studies [17]. However, this summary
publication was not able to overcome the limitation of
differences in sampling methods between the different
studies. Consequently, to date, comparability of general
population norm data between countries has been limited.Owing to the lack of high-quality European general
population norm data for the EORTC QLQ-C30, the
EORTC Quality of Life Group decided to fund a large-
scale cross-country project to collect norm data using a
commonmethodology across 13European countries. The
aim of the study was to generate up-to-date norm data for
the EORTC QLQ-C30 in a representative sample of the
adult population in Europe. In addition, norm data were
collected in Canada and USA for comparative purposes
[19]. In this article, we describe the general population
norm data sample collected from the German adult
population. While national-level data have already been
published as part of the core article [19], this article pro-
vides a more detailed overview of the German general
population normdata by stratifying the sample by sex and
age/sex. In addition, this article discusses similarities and
differences compared with the previously published
German general population samples that are adjusted
using the same weighting procedure as for our data.
2. Material and methods
2.1. Item selection and socio-demographic data
This study was part of a larger study aimed at gener-
ating European general population norm data for the
EORTC QLQ-C30 and its computerised adaptive test
(CAT) version, the EORTC CAT Core [20]. The main
study collected norm data in 15 countries in Europe and
North America [19,21].
The 30 items of the EORTC QLQ-C30 cover 15 do-
mains, of which five are function scales, nine are
symptom scales/items and one is a global health/QoL
scale. In addition, we collected data on sex, age,
educational attainment, relationship status, employment
status, presence of a range of doctor-diagnosed health
conditions/diseases and ethnicity.
2.2. Sampling and data collection
Samples were stratified by sex and age. We defined five
age groups (18e39, 40e49, 50e59, 60e69, 70 years),
leading to 10 strata (female/male*age groups), with an
anticipated sample size of n Z 100/stratum. Data were
collected via internet panels by GfK SE (www.gfk.com),
a panel research company with long-standing experience
with international surveys. GfK warrants panels to be
Table 1
Socio-demographic data of full German sample and sample stratified by sex (crude sample).
Sociodemographic variable Full sample (n Z 1006) Females (n Z 501) Males (n Z 505)
n %a n %a n %a
Age (years)
(mean, SD) 53.8 15.0 53.5 15.2 54.2 14.8
Age (years, in categories)
18e39 200 19.9 100 20.0 100 19.8
40e49 201 20.0 100 20.0 101 20.0
50e59 201 20.0 101 20.2 100 19.8
60e69 201 20.0 100 20.0 101 20.0
70 203 20.2 100 20.0 103 20.4
Education
Less than compulsory education 1 0.1 1 0.2 0 0.0
Compulsory (left school at the minimum school leaving age) 112 11.2 56 11.2 56 11.2
Some postcompulsory (some school after reaching school leaving age without
reaching university entrance qualification)
396 39.7 222 44.5 174 34.9
Postcompulsory below university 163 16.3 85 17.0 78 15.6
University degree (bachelor’s degree or equivalent level) 125 12.5 52 10.4 73 14.6
Postgraduate degree (master’s degree, doctorate or equivalent level) 201 20.1 83 16.6 118 23.6
Prefer not to answer 8 2 6
Employment status
Employed full time 370 37.1 127 25.6 243 48.4
Employed part time 111 11.1 90 18.1 21 4.2
Homemaker 43 4.3 39 7.9 4 0.8
Student 24 2.4 17 3.4 7 1.4
Unemployed 31 3.1 17 3.4 14 2.8
Retired 333 33.4 171 34.5 162 32.3
Self-employed 60 6.0 23 4.6 37 7.4
Other 26 2.6 12 2.4 14 2.8
Prefer not to answer 8 5 3
Relationship status
Single/not in a steady relationship 170 17.1 76 15.3 94 18.8
Married or in a steady relationship 652 64.4 296 59.7 356 71.1
Separated/divorced/widowed 175 17.6 124 25.0 51 10.2
Prefer not to answer 9 5 4
Health statusb
No health condition/disease 345 36.9 158 33.6 187 40.3
Chronic pain 270 28.9 156 33.2 114 24.6
Heart disease 74 7.9 32 6.8 42 9.1
Cancer (excluding basal cell carcinoma) 31 3.3 21 4.5 10 2.2
Depression 77 8.2 40 8.5 37 8.0
Chronic obstructive pulmonary disease (COPD) 34 3.6 15 3.2 19 4.1
Arthritis 152 16.3 99 21.1 53 11.4
Diabetes 118 12.6 47 10.0 71 15.3
Asthma 65 7.0 44 9.4 21 4.5
Anxiety disorder 37 4.0 17 3.6 20 4.3
Obesity 83 8.9 47 10.0 36 7.8
Drug/alcohol use disorder 10 1.1 1 0.2 9 1.9
Other 175 18.7 100 21.3 75 16.2
Prefer not to answer 70 30 40
a Percentage excludes those who preferred not to answer respective question.
b Sum of health conditions/diseases is larger than the total sample of n Z 1006, as respondents were able to check multiple response options.
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country. Data collection took place in March/April
2017. Further details on sampling, choice of countries,
stratification and so on are reported elsewhere [19].2.3. Statistical analyses
Socio-demographic data were analysed descriptively.
Calculated mean scores of the 15 EORTC QLQ-C30subscales were transformed to a range between 0 and
100 [4]. As a rough guide to determine group differences,
we applied a cut-off of 10 points to indicate moderate
group differences [22].
As the chosen sampling strategy was based on an
equal number of subjects per sex/age stratum (Refer to
Sampling and data collection), reported means based on
the total sample were weighted by Germany’s sex/age
distribution to achieve that the ‘German norm’ was as
Table 2
EORTC QLQ-C30 general population norm data for Germany. Mean
scores (M)/standard deviations (SD) by scales/symptoms, comparison
of weighteda and unweighted scores.
Domain Weighted Unweighted
M SD M SD
Function subscales
Physical functioning 82.8 21.2 82.0 21.5
Role functioning 80.8 27.2 80.3 27.4
Emotional functioning 73.9 24.7 75.1 24.2
Cognitive functioning 83.9 22.7 85.4 21.1
Social functioning 84.8 25.5 85.1 25.5
Symptom subscales/items
Fatigue 31.5 27.2 31.4 27.7
Nausea/vomiting 6.0 17.2 5.2 15.7
Pain 27.6 30.9 28.3 31.1
Dyspnoea 18.7 27.3 19.6 27.8
Insomnia 27.6 33.1 28.9 33.6
Appetite loss 10.1 23.3 9.3 22.2
Constipation 9.6 22.3 8.9 21.6
Diarrhoea 10.4 22.7 9.7 22.2
Financial difficulties 11.3 25.0 10.4 24.1
Global health/Quality of Life 67.0 21.8 65.9 22.2
EORTC QLQ-C30, European Organisation for Research and Treat-
ment of Cancer core questionnaire.
a Weighted by sex and age according to the United Nations,
Department of Economic and Social Affairs, population distribution
statistics for the year 2015 (United Nations, Department of Economic
and Social Affairs, Population Division (2017). World Population
Prospects: The 2017 Revision, DVD Edition).
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lation. Weights were derived from population distribu-
tion statistics for the year 2015 as published by the
United Nations, Department of Economic and Social
Affairs, Population Division population distribution
statistics [23]. To enable accurate comparison of the new
norm data with previously published German norm data
[15e17], the weighted sex/age structure of our popula-
tion was used to adjust the previously reported norm
scores following the Hjermstad et al. [10] procedure.
We used IBM SPSS Statistics, version 25, for all
analyses.
3. Results
3.1. Sample description
As shown in Table 1 (crude sample), the sample con-
sisted of 501 women and 505 men. The mean age was 54
years. Approximately 11% had less than or compulsory
education, while about one third had a university or
postgraduate degree. About one third was working full
time, and one third was retired. About two thirds were
married/in a steady relationship. Sixty-three percent of
study participants reported having a doctor-diagnosed
health condition/disease, with the most frequently re-
ported diseases being chronic pain (29%), arthritis (16%)
and diabetes (13%). As expected for a representative
German sample with the given age structure [24], men
had a higher educational level, and more men were in
full-time employment compared with women, while
more women than men worked either part time or were
homemakers. Furthermore, more women reported to be
separated/divorced/widowed and had at least one health
condition compared with men (Refer toTable 1 for
crude sample, Supplement Table 1 for weighted sample).
3.2. Overall HRQoL in Germany (weighted, unweighted)
Weighted mean scores for the function scales ranged
between 73.9 (emotional functioning) and 84.8 (social
functioning), while it was 67.0 for the global health/QoL
scale. Symptom scores ranged from 6.0 for nausea/
vomiting to 31.5 for fatigue.
To assess the impact of weighting on mean scores,
weighted and unweighted scores were compared. As
shown in Table 2, respective mean scores did not divert
by more than 1.5 points showing minimal impact of the
weighting procedure on the norm mean scores.
3.3. HRQoL by age
As shown in Table 3, data stratification by age suggested
that physical and role functioning tended to deteriorate
with increasing age, while particularly for emotionalfunctioning, the reverse seemed to be the case. In the
case of the latter, however, the youngest age group re-
ported a relatively low level of emotional functioning
compared with the other four function scales, with more
than 10 points difference between respective subscale’s
mean score. For cognitive functioning, the youngest age
group scored at least 5 points lower than any of the
other age groups, with highest scores observed in the age
group of 60e69 years. For global health/QoL, younger
respondents showed highest scores (71.4 points), which
monotonously decreased to 63.9 points reported by the
oldest age group.
For symptoms, largest age differences were observed
for pain, dyspnoea and insomnia, with younger re-
spondents reporting substantially lower scores than
older age groups. In contrast, the youngest age group
reported higher nausea/vomiting symptom burden; they
also tended to show highest symptom burden in appetite
loss, constipation, diarrhoea and financial difficulties
compared with older respondents with largely monoto-
nous decreases of symptom burden from young to old.
3.4. HRQoL by sex and age
In addition to stratification by age, we further divided
the sample into women (Table 4a) and men (Table 4b).
Table 3
EORTC QLQ-C30 general population norm data for adults in Germany. Mean scores (M)/standard deviations (SD) by scales/symptoms
stratified by age group (weighted data).
Domain Total (i.e. men and women combined)
Total 18e39 years 40e49 years 50e59 years 60e69 years 70 years
M SD M SD M SD M SD M SD M SD
Function subscales
Physical functioning 82.8 21.2 87.0 19.7 87.7 16.9 82.9 21.3 78.9 21.9 73.6 23.4
Role functioning 80.8 27.2 84.7 25.1 84.6 25.3 80.2 26.5 77.7 28.4 73.0 30.3
Emotional functioning 73.9 24.7 69.4 26.5 73.8 25.1 71.9 25.6 79.1 21.7 80.3 19.7
Cognitive functioning 83.9 22.7 79.8 26.9 86.2 20.4 84.8 21.0 88.9 16.6 84.9 20.5
Social functioning 84.8 25.5 84.5 25.9 84.0 26.9 83.8 25.5 86.7 25.3 85.9 23.7
Symptom subscales/items
Fatigue 31.5 27.2 31.0 25.3 33.5 27.7 30.8 27.3 29.2 28.1 33.1 29.1
Nausea/vomiting 6.0 17.2 9.7 22.2 4.2 15.0 4.9 13.6 4.0 13.1 3.6 12.6
Pain 27.6 30.9 21.9 29.0 24.4 29.0 29.9 30.3 32.8 32.9 35.0 33.1
Dyspnoea 18.7 27.3 13.7 23.4 16.1 24.5 18.9 27.2 23.2 29.2 27.0 32.2
Insomnia 27.6 33.1 22.1 30.7 26.9 32.1 32.1 36.3 30.2 34.3 32.0 33.0
Appetite loss 10.1 23.3 12.8 26.7 8.8 22.5 8.6 20.4 8.2 21.1 9.4 21.3
Constipation 9.6 22.3 12.3 24.9 8.4 23.1 8.6 19.8 8.2 20.5 7.5 19.8
Diarrhoea 10.4 22.7 12.7 23.7 8.5 21.4 11.8 25.6 7.4 18.8 8.9 21.1
Financial difficulties 11.3 25.0 14.0 28.0 10.8 25.4 9.9 21.9 9.5 24.2 9.3 22.1
Global health/Quality of Life 67.0 21.8 71.4 19.8 66.6 20.9 64.4 22.4 64.3 24.9 63.9 21.7
EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer core questionnaire.
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and role functioning but increase in emotional func-
tioning with increasing age was observed in both women
and men. However, observed low scores for emotional
functioning for the youngest age group were particularly
pronounced in women who reported >15 points differ-
ence between this subscale and any of the remaining
function subscales. For cognitive functioning, the
observed peak in the age group of 60e69 years was only
apparent in women, while the observed lower scores in
cognitive functioning reported by the youngest age
group were only seen in men. For symptoms, observed
age differences regarding dyspnoea and insomnia were
only apparent in women. In contrast, the observed age
difference regarding higher levels of nausea/vomiting,
appetite loss, constipation, diarrhoea and financial dif-
ficulty of the youngest age group compared with most
other age groups was only found in men.
When comparing self-reported health between
women and men globally, men scored slightly higher/
better on the global health/QoL scale and the function
scales, except for cognitive and social functioning
compared with women. Men also scored lower/better on
most symptom scales/items, except for nausea/vomiting
and diarrhoea. However, when comparing respective
total mean scores, none of these differences reached the
a priori defined 10-point threshold, and only one sub-
scale showed a difference of >5 points (pain, lower for
men). When exploring each age stratum, however, some
larger group differences were observed. For example,
large differences were seen in the youngest age group in
cognitive functioning with women scoring almost 10
points higher/better than men. Furthermore, womenaged 50e59 years reported substantially lower/worse
physical and role functioning and higher/worse symp-
tom burden for insomnia, pain and dyspnoea than men
of the same age group. Group differences in the next
older age group (60e69 years) were substantially
smaller, with the only marked difference observed for
insomnia in favour of men.
Stratified results by sex and age are further shown in
Fig. 1a/b (women) and Fig. 2a/b (men) for easier visu-
alisation of the findings.
4. Discussion
In this article, we present updated general population
norm data for Germany, which were obtained as part of
a large, multinational study collecting norm data across
15 countries in Europe and North America, thereby
applying a consistent data collection method throughout
[19]. The application of a common methodology is
particularly crucial to ensure that data can be compared
across countries and cultures. For the purpose of this
study, data collection was subcontracted to the panel
research company GfK. Collecting data via internet
panels is an efficient, cost-effective method to generate
norm data, and there is evidence from a comparable
study carried out by the Patient-Reported Outcomes
Measurement Information System initiative that these
data are representative of the general population.
Nevertheless, this same group recommends weighting of
scores to obtain a truly representative sample [25], a
method which is consistent with our procedure. While
weighting did not have a substantial impact on obtained
mean scores in our study, the direction of score
Table 4a
EORTC QLQ-C30 general population norm data for women in Germany. Mean scores (M)/standard deviations (SD) by scales/symptoms
stratified by age group (weighted data).
Domain Women
Total 18e39 years 40e49 years 50e59 years 60e69 years 70 years
M SD M SD M SD M SD M SD M SD
Function subscales
Physical functioning 81.4 21.3 88.0 17.4 86.6 18.3 78.0 22.4 78.3 23.0 72.1 22.8
Role functioning 79.7 27.5 86.7 22.5 84.2 24.9 75.4 27.4 75.8 29.9 71.3 31.7
Emotional functioning 73.1 25.3 68.7 26.4 73.8 27.4 70.1 26.2 77.2 23.3 79.3 20.9
Cognitive functioning 85.2 21.2 84.9 22.5 85.5 22.7 82.5 20.1 90.5 14.3 84.3 22.1
Social functioning 85.7 25.6 87.7 23.8 84.7 27.9 81.0 27.5 84.7 28.7 88.0 22.1
Symptom subscales/items
Fatigue 33.8 27.9 32.5 25.1 36.7 30.3 34.4 28.5 30.2 28.8 35.3 29.0
Nausea/vomiting 5.5 16.2 6.4 17.3 4.2 16.5 5.9 14.8 5.7 16.5 4.7 15.4
Pain 30.7 32.1 21.9 27.7 28.2 31.2 37.6 33.6 33.7 34.3 38.7 33.3
Dyspnoea 19.3 28.5 9.2 19.2 17.0 26.2 23.8 29.6 22.7 29.6 30.7 34.7
Insomnia 29.7 33.5 19.7 27.8 27.7 33.9 39.9 37.1 35.0 35.7 34.3 33.0
Appetite loss 10.7 23.4 10.1 24.4 10.7 25.0 10.6 20.5 10.0 24.0 12.0 23.0
Constipation 9.9 22.9 10.8 23.9 10.3 25.4 9.2 20.6 9.7 22.4 8.7 21.5
Diarrhoea 9.5 22.5 9.8 21.9 5.7 19.0 11.6 25.2 7.0 19.8 12.0 24.8
Financial difficulties 11.6 25.6 11.7 27.6 12.0 27.5 13.2 23.6 11.0 26.5 10.0 22.0
Global health/Quality of Life 65.8 22.0 72.3 18.2 65.3 22.3 60.1 22.8 63.8 26.6 62.6 21.0
EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer core questionnaire.
Table 4b
EORTC QLQ-C30 general population norm data for men in Germany. Mean scores (M)/standard deviations (SD) by scales/symptoms stratified
by age group (weighted data).
Domain Men
Total 18e39 years 40e49 years 50e59 years 60e69 years 70 years
M SD M SD M SD M SD M SD M SD
Function subscales
Physical functioning 84.3 21.0 86.0 21.6 88.7 15.4 87.8 19.1 79.5 20.8 75.7 24.2
Role functioning 82.0 26.8 82.7 27.3 85.0 25.9 85.0 24.8 79.7 26.8 75.2 28.3
Emotional functioning 74.7 24.0 70.1 26.6 73.7 22.7 73.7 25.0 81.2 19.8 81.7 18.0
Cognitive functioning 82.6 24.1 75.0 29.8 87.0 17.9 87.0 21.8 87.3 18.8 85.8 18.3
Social functioning 83.9 25.5 81.4 27.5 83.3 26.1 86.5 23.2 88.8 21.3 83.0 25.7
Symptom subscales/items
Fatigue 29.1 26.2 29.6 25.5 30.5 24.6 27.1 25.8 28.1 27.4 30.0 29.1
Nausea/vomiting 6.6 18.1 12.8 25.8 4.3 13.5 3.8 12.3 2.3 7.9 2.1 7.3
Pain 24.3 29.3 21.9 30.2 20.8 26.4 22.2 24.5 31.8 31.6 29.9 32.3
Dyspnoea 18.1 26.0 18.0 26.2 15.2 22.9 14.0 23.8 23.8 28.9 22.0 27.9
Insomnia 25.4 32.6 24.3 33.2 26.1 30.4 24.3 33.8 25.1 32.2 28.8 33.1
Appetite loss 9.6 23.2 15.4 28.6 6.9 19.6 6.7 20.1 6.3 17.5 5.8 18.4
Constipation 9.2 21.7 13.8 25.8 6.6 20.6 8.0 19.0 6.6 18.3 5.8 17.1
Diarrhoea 11.4 22.8 15.4 25.0 11.2 23.2 12.0 26.2 7.9 17.8 4.5 13.3
Financial difficulties 10.9 24.4 16.2 28.2 9.6 23.3 6.7 19.5 7.9 21.7 8.4 22.3
Global health/Quality of Life 68.2 21.5 70.5 21.3 68.0 19.5 68.7 21.3 64.8 23.2 65.7 22.6
EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer core questionnaire.
S. Nolte et al. / European Journal of Cancer 137 (2020) 161e170166adjustments was consistent with the higher weights given
to older strata compared with younger strata, hence,
consistent with age group differences reported in the
Results section of this article.
Some of our findings are in line with response pat-
terns that would be expected, such as the observed
decline in physical and role functioning with increasing
age. In contrast, comparatively low scores in cognitivefunctioning in young men were unexpected. However,
this finding is in line with other studies suggesting that
older adults frequently show a disconnection between
subjective and objective memory performance and sub-
sequently overestimate their cognitive functioning [26].
Coupled with possible downward comparison of the
older ages groups [27], that is, comparison of oneself to
people of the same age who are less cognitively able, as
Fig. 1. a) German EORTC QLQ-C30 general population normative data for global health status/quality of life and function subscales for
women by age group. b) German EORTC QLQ-C30 general population normative data for symptom subscales and items for women by
age group. EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer core questionnaire.
S. Nolte et al. / European Journal of Cancer 137 (2020) 161e170 167well as with lower demands due to retirement, this might
explain the relatively high self-reported cognitive func-
tioning in older respondents. As our data were obtained
via an online survey, it is also possible that older par-
ticipants were biased towards those who were suffi-
ciently (cognitively) capable and healthy to respond to
an electronic survey.
For the EORTC QLQ-C30 symptom scales, some
response patterns were again in the expected direction
(e.g. pain and dyspnoea), while other symptom scales
did not show any obvious trend. One exception was the
observation of some consistently higher symptom
burden in younger men (i.e. nausea/vomiting, appetite
loss, constipation and diarrhoea) which may be related
to differences in leisure activities (e.g. the high incidence
of binge drinking, especially in younger men, might
explain some of the findings [28]). In the context of
symptom scales, however, it needs to be stressed that
our sample is based on respondents from the general
population and many symptoms are included in theEORTC QLQ-C30 because of particular relevance to
patients with cancer during or after treatment. There-
fore, some floor effects in the symptom scales in
particular e regardless of age e can be expected when
seeking responses to these items from the general
population.
As earlier publications already established general
population norm data for Germany, we compared our
data to these publications [15e17]. Of note, we applied
the same weights to the results from the earlier publi-
cations as applied to the data in this article to ensure
comparability. First, it is striking that the general pop-
ulation data published by Schwarz and Hinz [15] and
Hinz et al. [17] reported better scores (i.e. higher func-
tioning/lower symptom scores) for all 15 EORTC QLQ-
C30 scales than found in our data. For women, one
function and four symptom scales/items showed de-
viations of >10 points. Even greater differences were
seen for men, with four function and three symptom
scales/items showing a deviation of >10 points. In
Fig. 2. a) German EORTC QLQ-C30 general population normative data for global health status/quality of life and function subscales for
men by age group. b) German EORTC QLQ-C30 general population normative data for symptom subscales and items for men by age
group. EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer core questionnaire.
S. Nolte et al. / European Journal of Cancer 137 (2020) 161e170168contrast, normative data reported by Waldmann et al.
[16] are largely in line with our data, with the only dif-
ference >5 points seen in emotional functioning in
women (mean score 6.1 points higher/better in our data)
and dyspnoea in men (5.0 points higher/worse dyspnoea
score in our data) [16]. It appears that especially male
respondents in the studies by Schwarz and Hinz [15] and
Hinz et al. [17] reported high functioning scores with
>90 points in all but the emotional function scale and
comparatively low symptom burden compared with our
and the Waldmann et al. [16] data. Hence, the former
samples may have consisted of respondents who may
have been too healthy to be representative of the
German general population. To substantiate this notion,
we compared our sample with national data collected as
part of the German Health Update (GEDA) study, a
large-scale health monitoring study in Germany with
more than 20,000 participants [29,30]. Owing to space
constraints, we cannot show all details of this compar-
ison, but in summary, we found that the GEDA 12-month prevalence data of, for example, asthma (6.2%
GEDA; 7.0% in our data set) and depression (8.1%;
8.2%) in the adult population are remarkably similar,
while chronic obstructive pulmonary disease prevalence
is even lower in our data set (5.8%; 3.6%) [29,30]. Sixty-
three percent of our sample reported at least one health
condition/disease (lifetime prevalence), with presence of
a health condition being clearly associated with worse
functioning/higher symptom burden (data not shown).
We, therefore, believe that our sampling should have
captured a more representative sample of the German
general population compared with previously published
samples.
This study has strengths and limitations. To our
knowledge, the cross-country norm data project funded
by the EORTC Quality of Life Group is the largest
study worldwide to generate general population norm
data for the EORTC QLQ-C30. These were generated
across 15 countries in Europe and North America,
thereby applying a common methodology. To achieve
S. Nolte et al. / European Journal of Cancer 137 (2020) 161e170 169quotas across countries, we subcontracted data collec-
tion to one of the largest panel research companies
worldwide that ensure representativeness of their online
panels. However, while we believe the sampling strategy
via GfK’s online panels is one of the study’s strengths,
there are limitations. Although internet access and usage
has substantially increased over the last two decades,
with 88% of German households having internet access,
older citizens use the internet substantially less
frequently than younger generations. While generally
well over 95% of the German population between 10
and 64 years uses the internet, this percentage drops to
75% for men and 60% for women, respectively, in the
age group 65 years [31]. Therefore, it cannot be ruled
out that especially the oldest age group in our sample
may not be representative of the general population of
that age group. However, self-selection bias is not
unique to our study but is a general concern in
population-based surveys. For example, there is evi-
dence suggesting that participants in health surveys
report better health-directed activities and health status
overall than those who do not participate [32,33]; how-
ever, another study found that self-selection hardly
influenced scores [34]. In summary, while online surveys
are not free of bias, alternative data collection methods
come at the expense of other biases. For example, a
serious concern in the collection of population data
using alternative sampling techniques is non-response
bias [33], which was not as much of an issue in our
online panel [19]. Furthermore, one strategy to over-
come a potential limitation of coverage error by means
of quota sampling was to weight our data by Germany’s
sex/age distribution using the population distribution
statistics published by the United Nations [23]. There-
fore, while bias cannot be ruled out in any population
health survey, the EORTC QLQ-C30 general popula-
tion norm data for Germany presented herein are the
best available data to date.5. Conclusions
This study presents updated EORTC QLQ-C30 general
population norm data for Germany assessed via an
online panel. The current data show some discrepancies
with earlier publications on norm data from the general
German population. Following our earlier discussion,
we are confident that our data collection as carried out
by GfK yielded high-quality data. Furthermore, the
data presented herein were gathered as part of a multi-
national study which comes with the advantage of
enabling valid inter-country comparisons. In conclu-
sion, this study presents updated EORTC QLQ-C30
general population norm data for Germany that we
recommend using for comparative purposes with data
obtained from patients with cancer, in particular also
for use in multinational studies.Ethical statement
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